Okeanis Eco Tankers Corp. – Announcement of Availability of 2024 Annual Report on Form 20-F
ATHENS, Greece, March 31, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the 'Company' or 'OET') (NYSE:ECO / OSE:OET), announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2024 (the 'Annual Report') has been filed with the U.S. Securities and Exchange Commission (the 'SEC'). The Annual Report may be downloaded from the SEC's website (http://www.sec.gov) and is also available under the Investor Relations section (Financial Reports and Webcasts) of the Company's website (www.okeanisecotankers.com). Hard copies of the Company's complete audited financial statements can be obtained, free of charge, upon request by contacting the Company at ir@okeanisecotankers.com or by writing to Okeanis Eco Tankers Corp., Ethnarchou Makariou av. & 2 D. Falireos st., 18547 Neo Faliro, Greece.
Contacts
Company:Iraklis Sbarounis, CFOTel: +30 210 480 4200ir@okeanisecotankers.com
Investor Relations / Media Contact:Nicolas Bornozis, PresidentCapital Link, Inc.230 Park Avenue, Suite 1540, New York, N.Y. 10169Tel: +1 (212) 661-7566okeanisecotankers@capitallink.com
About OET
OET is a leading international tanker company providing seaborne transportation of crude oil and refined products. The Company was incorporated on April 30, 2018 under the laws of the Republic of the Marshall Islands and is listed on Oslo Børs under the symbol OET and the New York Stock Exchange under the symbol ECO. The sailing fleet consists of six modern scrubber-fitted Suezmax tankers and eight modern scrubber-fitted VLCC tankers.
Forward-Looking Statements
This communication contains 'forward-looking statements', including as defined under U.S. federal securities laws. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements include statements about the Company's expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts or that are not present facts or conditions. Words or phrases such as 'anticipate,' 'believe,' 'continue,' 'estimate,' 'expect,' 'hope,' 'intend,' 'may,' 'ongoing,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'will' or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. The Company's actual results could differ materially from those anticipated in forward-looking statements for many reasons, including as described in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'). Accordingly, you should not unduly rely on these forward-looking statements, which speak only as of the date of this communication. Factors that could cause actual results to differ materially include, but are not limited to, the Company's operating or financial results; the Company's liquidity, including its ability to service its indebtedness; competitive factors in the market in which the Company operates; shipping industry trends, including charter rates, vessel values and factors affecting vessel supply and demand; future, pending or recent acquisitions and dispositions, business strategy, areas of possible expansion or contraction, and expected capital spending or operating expenses; risks associated with operations; broader market impacts arising from war (or threatened war) or international hostilities; risks associated with pandemics, including effects on demand for oil and other products transported by tankers and the transportation thereof; and other factors listed from time to time in the Company's filings with the SEC. Except to the extent required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based. You should, however, review the factors and risks the Company describes in the reports it files and furnishes from time to time with the SEC, which can be obtained free of charge on the SEC's website at www.sec.gov.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.Sign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
UBS Upholds Buy Recommendation on Deckers Outdoor (DECK)
On June 5, UBS analysts maintained a Buy rating on Deckers Outdoor Corporation (NYSE:DECK) with a price target of $169. The analysts expect Decker's EPS to top market estimates over the coming year as sales projections increase for its Hoka brand. They also anticipate UGG to keep up its record as a major global casual footwear brand. A customer browsing a retail store, finding the perfect footwear for their casual outfits. The analysts were confident that Deckers Outdoor Corporation (NYSE:DECK) could deliver a low double-digit compound annual sales growth. They forecast that this growth could drive Deckers' forward PE ratio over 20x, compared to the present 16.7x. The $169 price target by UBS reflects a 60% upside for DECK. The stock has plummeted nearly 47% over the last six months, which signals a buying opportunity. After discussions with company management on June 4, the analysts were optimistic about Deckers Outdoor Corporation (NYSE:DECK)'s potential for growth. Despite the market showing caution with reference to the Hoka brand's capacity to sustain robust growth, UBS believes that DECK is perfectly tackling concerns about industry competition, evolving fashion trends, and dependence on Clifton and Bondi franchises. The analysts see double-digit revenue growth for Hoka in the next few years. Deckers Outdoor Corporation (NYSE:DECK) designs and markets premium footwear and apparel worldwide with brands like UGG and HOKA. The company was established in 1973 and is headquartered in Goleta, California. While we acknowledge the potential of DECK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio
Yahoo
4 hours ago
- Yahoo
Kentucky Basketball Beats Cap Proposal With NIL Power Play
Kentucky Basketball Beats Cap Proposal With NIL Power Play originally appeared on Athlon Sports. When it comes to men's college basketball, few schools wield influence like Kentucky, and this week, they proved it again. As the NCAA's House settlement edges closer to implementation, Kentucky stepped into the spotlight, fiercely opposing a proposed NIL cap that could've limited its competitive edge. Advertisement The crux of the debate centered around the $20.5 million NIL spending cap schools would soon face across all athletic programs. But behind closed SEC doors, a separate proposal was on the table, one that would restrict how much of that total could be allocated to each sport. That's where Kentucky drew the line. According to Yahoo Sports' Ross Dellenger, Kentucky 'was a pretty big voice in the room' advocating to kill that per-sport cap. The message was clear: the Wildcats didn't want limitations hampering their marquee basketball program, long a cornerstone of both the school's identity and national recruiting dominance. The result? The SEC dropped the proposed per-sport NIL limit, for now. At least for the 2025-26 calendar year, powerhouse programs like Kentucky will have free rein to allocate their NIL funds however they see fit within the $20.5 million cap. This means Coach Mark Pope and his staff can remain aggressive in pursuing top-tier talent without worrying about hitting a sport-specific ceiling. Kentucky Wildcats head coach Mark Pope.© Randy Sartin-Imagn Images While the move boosts Kentucky's flexibility, it also raises critical questions about equity and transparency. As of early June, UK has yet to release a breakdown of how it plans to distribute NIL dollars across all sports. That silence has sparked speculation about how much support non-revenue programs will receive in this new era. Advertisement Still, for fans of Kentucky basketball, this is a major victory. In a landscape where elite talent now chooses programs based as much on NIL potential as championship pedigree, Kentucky just kept itself near the top of the food chain. Kentucky's bold NIL stance didn't just influence policy, it preserved its basketball identity in the most financially competitive era college sports has ever seen. Related: Michigan Running Back's Groundbreaking NIL Deal Redefines College Football Related: Curry Brand Signs Chinese Phenom in Global NIL Power Move This story was originally reported by Athlon Sports on Jun 7, 2025, where it first appeared.
